We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Arcturus Therapeutics

News List

Arcturus Therapeutics, Catalent announce partnership to manufacture mRNA-based Covid-19 pharmaceutical-business-review
May 08, 2020
Arcturus Therapeutics Holdings, a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19) .
Arcturus, Catalent Partner to Manufacture COVID-19 Vaccine contractpharma
May 05, 2020
The manufacture of LUNAR-COV19 at Catalent’s drug substance biomanufacturing facility in Madison, WI will support human clinical studies.
Arcturus Therapeutics partners with medical school for coronavirus vaccine pharmaceutical-technology
March 09, 2020
Arcturus Therapeutics, a RNA medicines company, and Duke-NUS Medical School have partnered to develop a coronavirus Covid-19 vaccine for Singapore.